- $107.77m
- $59.11m
- $52.85m
Annual balance sheet for AMREP, fiscal year end - April 30th, USD millions except per share, conversion factor applied.
2022 April 30th | 2023 April 30th | 2024 April 30th | 2025 April 30th | 2026 April 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 15.7 | 20 | 29.7 | 39.5 | 52.3 |
| Total Inventory | |||||
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 10.4 | 15.1 | 14.3 | 17.1 | 18.3 |
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Other Assets | |||||
| Total Assets | 94.9 | 116 | 123 | 134 | 145 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 11.8 | 4.89 | 4.78 | 3.81 | 4.04 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 83.2 | 111 | 118 | 130 | 141 |
| Total Liabilities & Shareholders' Equity | 94.9 | 116 | 123 | 134 | 145 |
| Total Common Shares Outstanding |